Drug Database
Back to search

Belgium· BE-AMP-SAM265912-00

Co-Lisinopril Viatris 20 mg - 12.5 mg

A lisinopril und diuretika product containing hydrochlorothiazide, registered in Belgium by Viatris GX. The same ATC class is registered in 11 of our 19 countries.

ATC C09BA03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedCo-Lisinopril Viatris 20 mg - 12.5 mgATCC09BA03REGISTER NO.BE-AMP-SAM265912-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about hydrochlorothiazideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lisinopril und diuretika is registered in 11 of 19 countries.

Countries holding a registration under ATC C09BA03 (lisinopril und diuretika), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search lisinopril und diuretika products by name

Lisinopril und diuretika · ATC C09BA03

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Hydrochlorothiazide
Manufacturer
Viatris GX
Country
Belgium (BE)
ATC code
C09BA03
ATC class
Lisinopril und Diuretika
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    2188019
  • be_apb
    0779249

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

67 interactions on record for lisinopril und diuretika.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check lisinopril und diuretika against other medicinesHow interaction checks work

Lisinopril und diuretika · interactions on record

67 records

67 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Lisinopril und diuretika in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lisinopril und diuretika products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Hct G.L.
  • Bulgaria · Hypodehydra, Дехидразид
  • Cyprus · Didralin, Hydrochlorothiazide Remedica
  • Czechia · Hydrochlorothiazid Léčiva
  • Germany · Hct 089pharm, Hct 1 A Pharma
  • Denmark · Hydrochlorothiazide Orifarm, Hydromed
  • Estonia · Hypothiazid
  • Spain · Drine, Esidrex
  • Finland · Hydrex, Hydrex Semi
  • France · Esidrex, Hydrochlorothiazide Arrow
  • United Kingdom (Northern Ireland) · Hydrochlorothiazide Aspire Pharma
  • Greece · Diuren, Losazide
  • Hungary · Hypothiazid
  • Iceland · Hydromed
  • Italy · Esidrex, Idroclorotiazide Aurobindo
  • Lithuania · Hypothiazid
  • Latvia · Hypothiazid
  • Netherlands · Hydrochloorthiazide 1a Pharma, Hydrochloorthiazide Aurobindo
  • Norway · Esidrex, Hydrochlorothiazide Orifarm
  • Poland · Hydrochlorothiazide Aurovitas, Hydrochlorothiazidum Polpharma
  • Portugal · Hidroclorotiazida Bluefish, Hidroclorotiazida Generis
  • Romania · Nefrix
  • Sweden · Esidrex, Hydrochlorothiazide Bluefish
  • Slovakia · Hydrochlorothiazid Léčiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ee88882d-549d-420b-a63e-7af24c6ab370
GET /v1/drugs/ee88882d-549d-420b-a63e-7af24c6ab370?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Co-Lisinopril Viatris 20 mg - 12.5 mg",
  "name_fr": "Co-Lisinopril Viatris 20 mg - 12.5 mg",
  "name_nl": "Co-Lisinopril Viatris 20 mg - 12.5 mg",
  "amp_code": "SAM265912-00",
  "strengths": [
    "12.5000",
    "12.5000",
    "12.5000",
    "12.5000",
    "21.7800",
    "21.7800",
    "21.7800",
    "21.7800",
    "20.0000",
    "20.0000",
    "20.0000",
    "20.0000"
  ],
  "pack_count": 7,
  "substances": [
    "Hydrochlorothiazide",
    "Lisinopril Dihydrate",
    "Lisinopril",
    "Mannitol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Lisinopril and Diuretics",
  "authorisation_numbers": [
    "BE265912"
  ]
}
API referenceMCP serverPlans

See everything about lisinopril und diuretika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console